Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127982811 | 12798281 | 1 | I | 201603 | 20160927 | 20160930 | 20160930 | EXP | FR-JNJFOC-20160926933 | JANSSEN | 61.72 | YR | A | M | Y | 0.00000 | 20160930 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127982811 | 12798281 | 1 | SS | ZYTIGA | ABIRATERONE ACETATE | 1 | Oral | Y | Y | 0 | TABLET | ||||||||
127982811 | 12798281 | 2 | PS | ZYTIGA | ABIRATERONE ACETATE | 1 | Oral | Y | Y | 202379 | TABLET | ||||||||
127982811 | 12798281 | 3 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
127982811 | 12798281 | 4 | SS | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
127982811 | 12798281 | 5 | SS | ROCEPHINE | CEFTRIAXONE SODIUM | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
127982811 | 12798281 | 6 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | Y | 0 | 1 | G | UNSPECIFIED | |||||||
127982811 | 12798281 | 7 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | IN THE EVENING | Y | 0 | 40 | MG | UNSPECIFIED | QD | |||||
127982811 | 12798281 | 8 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | IN THE EVENING | Y | 0 | 20 | GTT | UNSPECIFIED | ||||||
127982811 | 12798281 | 9 | SS | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | Unknown | IN THE EVENING | Y | 0 | UNSPECIFIED | ||||||||
127982811 | 12798281 | 10 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | D | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127982811 | 12798281 | 1 | Prostate cancer |
127982811 | 12798281 | 2 | Prostate cancer |
127982811 | 12798281 | 3 | Product used for unknown indication |
127982811 | 12798281 | 4 | Product used for unknown indication |
127982811 | 12798281 | 5 | Product used for unknown indication |
127982811 | 12798281 | 6 | Product used for unknown indication |
127982811 | 12798281 | 7 | Product used for unknown indication |
127982811 | 12798281 | 8 | Product used for unknown indication |
127982811 | 12798281 | 9 | Product used for unknown indication |
127982811 | 12798281 | 10 | Prostate cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127982811 | 12798281 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127982811 | 12798281 | Hepatitis | Hepatitis |
127982811 | 12798281 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127982811 | 12798281 | 1 | 20160308 | 201603 | 0 | |
127982811 | 12798281 | 2 | 20160801 | 201609 | 0 | |
127982811 | 12798281 | 3 | 201609 | 0 | ||
127982811 | 12798281 | 4 | 201609 | 0 | ||
127982811 | 12798281 | 5 | 20160830 | 201609 | 0 | |
127982811 | 12798281 | 6 | 201609 | 0 | ||
127982811 | 12798281 | 7 | 201609 | 0 | ||
127982811 | 12798281 | 8 | 201609 | 0 | ||
127982811 | 12798281 | 9 | 201609 | 0 | ||
127982811 | 12798281 | 10 | 20160801 | 0 |